Eli Lilly

FDA approves new Alzheimer's treatment, donanemab from Eli Lilly

FDA Approves Eli Lilly's New Alzheimer's Drug For Early Disease Symptoms

Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports

Eli Lilly drug shown to slow Alzheimer’s progression

Alzheimer’s trial shows clear benefits and significant risks of Eli Lilly antibody

Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease

‘It’s not a miracle drug’: Eli Lilly’s antibody slows Alzheimer’s disease but safety issues linger

Alzheimer’s Blood Test That Could Help Diagnose Disease Earlier Is Being Developed By Eli Lilly And Roche

Eli Lilly Slashes Insulin Prices Up To 70% And Caps Out-Of-Pocket Costs At $35

Eli Lilly to Cut Insulin Price and Cap Monthly Out of Pocket Costs at $35

Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocket

F.D.A. Clears Monoclonal Antibody Drug From Eli Lilly

Eli Lilly's combo therapy for COVID-19 cuts serious illness and death in large study